- Home
- SUPN vs AMSC Comparison
SUPN vs AMSC Comparison
Compare SUPN & AMSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- AMSC
- Stock Information
- Founded
- SUPN 2005
- AMSC 1987
- Country
- SUPN United States
- AMSC United States
- Employees
- SUPN N/A
- AMSC N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- AMSC Metal Fabrications
- Sector
- SUPN Health Care
- AMSC Consumer Discretionary
- Exchange
- SUPN Nasdaq
- AMSC Nasdaq
- Market Cap
- SUPN 2.6B
- AMSC 2.6B
- IPO Year
- SUPN 2012
- AMSC 1991
- Fundamental
- Price
- SUPN $44.80
- AMSC $60.49
- Analyst Decision
- SUPN Buy
- AMSC Strong Buy
- Analyst Count
- SUPN 2
- AMSC 2
- Target Price
- SUPN $43.00
- AMSC $34.00
- AVG Volume (30 Days)
- SUPN 654.2K
- AMSC 927.0K
- Earning Date
- SUPN 11-03-2025
- AMSC 10-29-2025
- Dividend Yield
- SUPN N/A
- AMSC N/A
- EPS Growth
- SUPN 1411.53
- AMSC N/A
- EPS
- SUPN 1.14
- AMSC 0.39
- Revenue
- SUPN $665,125,000.00
- AMSC $254,886,000.00
- Revenue This Year
- SUPN $4.84
- AMSC $28.23
- Revenue Next Year
- SUPN $17.69
- AMSC $11.78
- P/E Ratio
- SUPN $38.93
- AMSC $153.16
- Revenue Growth
- SUPN 5.55
- AMSC 63.73
- 52 Week Low
- SUPN $29.16
- AMSC $13.98
- 52 Week High
- SUPN $46.79
- AMSC $61.00
- Technical
- Relative Strength Index (RSI)
- SUPN 58.16
- AMSC 72.13
- Support Level
- SUPN $43.44
- AMSC $54.89
- Resistance Level
- SUPN $46.72
- AMSC $57.30
- Average True Range (ATR)
- SUPN 1.08
- AMSC 2.82
- MACD
- SUPN -0.48
- AMSC 0.77
- Stochastic Oscillator
- SUPN 40.60
- AMSC 95.77
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About AMSC American Superconductor Corporation
American Superconductor Corp generates the ideas, technologies, and solutions that meet the world's demand for smarter, cleaner, and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively, and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency, and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.